Comparative in vitro surveillance of amoxicillin-clavulanic acid and four oral comparators against 21,232 clinical isolates from Europe

D. Hoban, S. Bouchillon, J. L. Johnson, G. Zhanel, D. Butler, Kay Saunders, L. A. Miller, J. Poupard

Research output: Contribution to journalArticlepeer-review

Abstract

The present study was conducted to determine the in vitro activity of amoxicillin-clavulanic acid compared to that of four newer antimicrobial agents (ampicillin, azithromycin, cefuroxime and trimethoprim-sulfamethoxazole). All of the agents were tested against 21,232 recent clinical isolates encompassing 37 species submitted from 16 European countries between 1997 and 1999. After 20 years of clinical use, amoxicillin-clavulanic acid continues to retain much of its initial activity against targeted gram-positive organisms, selected gram-negative organisms and major respiratory pathogens.
Original languageEnglish
Pages (from-to)261-267
Number of pages7
JournalEuropean Journal of Clinical Microbiology & Infectious Diseases
Volume22
Issue number4
DOIs
Publication statusPublished - 2003

Fingerprint

Dive into the research topics of 'Comparative in vitro surveillance of amoxicillin-clavulanic acid and four oral comparators against 21,232 clinical isolates from Europe'. Together they form a unique fingerprint.

Cite this